Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Deva Holding ASIST:DEVA +3.78%66 PB Ratio is 0.50 as of Aug. 08, 2026, which is 66% below its 10-year median of 1.49. GuruFocus rates IST:DEVA with a GF Score™ of 66/100 and a GF Value™ of ₺82.61 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 921 Drug Manufacturers companies, Deva Holding AS ranks better than 92.62% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-08), Deva Holding AS's share price is ₺71.45. Deva Holding AS's Book Value per Share for the quarter that ended in Mar. 2026 was ₺144.21. Hence, Deva Holding AS's PB Ratio of today is 0.50.
The historical rank and industry rank for Deva Holding AS's PB Ratio or its related term are showing as below:
IST:DEVA'
s PB Ratio Range Over the Past 10 Years
Min: 0.41 Med: 1.49 Max: 4.17
Current: 0.5
During the past 13 years, Deva Holding AS's highest PB Ratio was 4.17. The lowest was 0.41. And the median was 1.49.
IST:DEVA's PB Ratio is ranked better than 92.62% of 921
companies
in the Drug Manufacturers industry
Industry Median: 1.96
vs IST:DEVA: 0.50
During the past 12 months, Deva Holding AS's average Book Value Per Share Growth Rate was 26.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 31.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 84.40% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 62.40% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Deva Holding AS was 135.50% per year. The lowest was -9.20% per year. And the median was 15.90% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Deva Holding AS PB Ratio Related Terms
Deva Holding AS PB Ratio Historical Data
* Premium members only.
The historical data trend for Deva Holding AS's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Deva Holding AS's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Deva Holding AS PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Deva Holding AS's PB Ratio distribution charts can be found below:
* The bar in red indicates where Deva Holding AS's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Deva Holding AS's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Deva Holding AS (IST:DEVA) has a PB Ratio of 0.50 as of Aug. 08, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Deva Holding AS and its competitors. This is 66% below median its historical median of 1.49. Over the past decade, Deva Holding AS's PB Ratio has ranged from 0.41 to 4.17. According to the industry distribution chart, Deva Holding AS ranks #68 out of 921 companies in the Drug Manufacturers industry, placing it in the top 7.4%.
Is Deva Holding AS's PB Ratio too high?
Deva Holding AS's current PB Ratio of 0.50 is 66% below median its 10-year median of 1.49. Over the past 10 years, this metric has ranged from a low of 0.41 to a high of 4.17. The Drug Manufacturers industry median PB Ratio is 1.96. Deva Holding AS's value of 0.50 is 74.5% below this industry median. Based on the distribution chart, Deva Holding AS ranks #68 out of 921 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Deva Holding AS has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Deva Holding AS's PB Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Deva Holding AS ranks #68 out of 921 companies for PB Ratio. This places Deva Holding AS in the top 7% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.96. Deva Holding AS's value of 0.50 is 74.5% below this benchmark. Historically, Deva Holding AS's own PB Ratio has ranged from 0.41 to 4.17 over the past decade. While the company's 10-year median is 1.49 vs. the industry median of 1.96, Deva Holding AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.96, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Deva Holding AS's current PB Ratio of 0.50 is 74.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Deva Holding AS and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Deva Holding AS's current PB Ratio is 0.50, which is 66% below median its own 10-year median of 1.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Deva Holding AS stock overvalued right now?
Based on GuruFocus' analysis, Deva Holding AS (IST:DEVA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₺82.61, compared to a current price of ₺71.45 — trading 13.5% below its estimated fair value. The current PB Ratio is 0.50, which is 66% below median its 10-year median of 1.49 and 74.5% below the Drug Manufacturers industry median of 1.96. Deva Holding AS's overall GF Score™ is 66/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Deva Holding AS (IST:DEVA), the current PB Ratio is 0.50 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Deva Holding AS (IST:DEVA) Overvalued in 2026?
Based on GuruFocus' analysis, Deva Holding AS stock appears to be undervalued.
The current stock price of ₺71.45 is trading 13.5% below its estimated GF Value™ of ₺82.61.
GuruFocus considers Deva Holding AS to be Modestly Undervalued.
Key valuation signals for IST:DEVA:
PB Ratio: 0.50 (66% below median its 10-year median of 1.49)
GF Value™: ₺82.61 vs. price of ₺71.45 (13.5% below fair value)
Industry Position: 74.5% below the Drug Manufacturers median (#68 of 921)
No single metric tells the full story. See the IST:DEVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Deva Holding AS is a Turkey-based generic medicine manufacturer. It is engaged in manufacturing and marketing of medicinal products for human use and raw materials. The company also carries out the manufacturing of veterinary drugs, eau de cologne, and medical ampoules. It produces medicines for antineoplastic agents, cardiovascular system, dermatological products, nervous system, respiratory system, urogenital system, among others. It exports pharmaceuticals and pharmaceutical raw materials in countries including Switzerland, Germany, the Netherlands, the United Kingdom and others.
66GF Score
Get the complete analysis for IST:DEVA
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:DEVA has been successfully added to your 
